ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,397Medicare Part D Prescriptions Filled, Including Refills

Rank: 282 out of 1185

$475K Total Retail Price of All Prescriptions

Rank: 297 out of 1185

476 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
56% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 476 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 476 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

1% of this provider’s 7,325 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
WARFARIN SODIUM 289 270 1 21
FUROSEMIDE 286 228 2 8
LISINOPRIL 280 223 3 4
LEVOTHYROXINE SODIUM 258 237 4 3
AMLODIPINE BESYLATE 204 180 5 1
OMEPRAZOLE 202 190 6 6
SIMVASTATIN 190 144 7 5
DONEPEZIL HCL 172 172 8 32
METOPROLOL TARTRATE 148 118 9 10
METOPROLOL SUCCINATE 148 137 9 20
PRAVASTATIN SODIUM 144 124 11 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 135 123 12 14
RANITIDINE HCL 126 109 13 17
FAMOTIDINE 124 113 14 69
MIRTAZAPINE 118 118 15 57
CITALOPRAM HBR 113 108 16 22
TRAMADOL HCL 99 88 17 16
HYDROCODONE-ACETAMINOPHEN 97 84 S3 18 2
CLOPIDOGREL 96 81 19 31
CARVEDILOL 95 93 20 24
METFORMIN HCL 90 85 21 9
CHLORTHALIDONE 84 76 22 117
HYDROCHLOROTHIAZIDE 80 74 23 12
LANTUS 78 42 24 66
LANTUS SOLOSTAR 76 76 25 104
PLAVIX 76 67 25 45
AZITHROMYCIN 74 63 27 39
ZOLPIDEM TARTRATE 74 69 27 15
CRESTOR 74 71 27 23
TRAZODONE HCL 68 62 30 38
FLUTICASONE PROPIONATE 67 56 31 29
GABAPENTIN 67 67 31 13
POTASSIUM CHLORIDE 64 56 33 18
AMLODIPINE BESYLATE-BENAZEPRIL 64 58 33 42
FLUOXETINE HCL 64 42 33 52
ALBUTEROL SULFATE 63 58 36 174
CLONIDINE HCL 60 54 37 47
PREDNISONE 60 42 37 33
HYDRALAZINE HCL 60 47 37 112
NEXIUM 59 54 40 19
ESCITALOPRAM OXALATE 59 49 40 79
ATORVASTATIN CALCIUM 59 56 40 11
MELOXICAM 58 48 43 27
METFORMIN HCL ER 57 47 44 35
OXCARBAZEPINE 57 57 44 288
ISOSORBIDE MONONITRATE ER 56 55 46 48
LEVOFLOXACIN 55 51 47 109
NAMENDA 54 54 48 43
KLOR-CON 10 52 52 49 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 4, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.